Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Johnson

Showing results (291-300 of 306) with videos related to

Pageof 31
Sort By:
JAMA Dermatology|August 30, 2023
Gut Microbiome in Patients With Early-Stage and Late-Stage MelanomaRussell G Witt, Samuel H Cass, Tiffaney Tran, et al.
Journal of Clinical Microbiology|July 11, 2025
Multicenter evaluation of the QIAstat-Dx Gastrointestinal Panel 2, a multiplex PCR platform for the diagnosis of acute gastroenteritisWendy A Szymczak, Anne Line Engsbro, Jan Gorm Lisby, et al.
American Journal of Respiratory and Critical Care Medicine|June 26, 2025
Addressing Knowledge Gaps in the Early Detection of Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation: An Official American Thoracic Society Research StatementGuang-Shing Cheng, Ajay Sheshadri, Jane Turner, et al.
Brain : a Journal of Neurology|November 12, 2024
Multicentre analysis of seizure outcome predicted by removal of high-frequency oscillationsVasileios Dimakopoulos, Jean Gotman, Petr Klimes, et al.
Haematologica|May 20, 2017
The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtypeCarolina Schinke, Antje Hoering, Hongwei Wang, et al.
Oncoimmunology|November 15, 2021
Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in <i>Braf</i>-mutated melanomaMichael G White, Robert Szczepaniak Sloane, Russell G Witt, et al.
Clinical Medicine (London, England)|January 26, 2022
Utility of severity assessment tools in COVID-19 pneumonia: a multicentre observational studyAsim Ahmed, Sayed A Alderazi, Rumaisa Aslam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2023
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal GammopathiesLeire Burgos, Luis-Esteban Tamariz-Amador, Noemi Puig, et al.
Cancer Research|September 15, 2020
Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward OsimertinibYuting Sun, Brooke A Meyers, Barbara Czako, et al.
Nature|June 15, 2022
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapyChristopher P Vellano, Michael G White, Miles C Andrews, et al.
Pageof 31

Showing results (291-300 of 306) with videos related to

Sort By:
Pageof 31
JAMA Dermatology|August 30, 2023
Gut Microbiome in Patients With Early-Stage and Late-Stage MelanomaRussell G Witt, Samuel H Cass, Tiffaney Tran, et al.
Journal of Clinical Microbiology|July 11, 2025
Multicenter evaluation of the QIAstat-Dx Gastrointestinal Panel 2, a multiplex PCR platform for the diagnosis of acute gastroenteritisWendy A Szymczak, Anne Line Engsbro, Jan Gorm Lisby, et al.
American Journal of Respiratory and Critical Care Medicine|June 26, 2025
Addressing Knowledge Gaps in the Early Detection of Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation: An Official American Thoracic Society Research StatementGuang-Shing Cheng, Ajay Sheshadri, Jane Turner, et al.
Brain : a Journal of Neurology|November 12, 2024
Multicentre analysis of seizure outcome predicted by removal of high-frequency oscillationsVasileios Dimakopoulos, Jean Gotman, Petr Klimes, et al.
Haematologica|May 20, 2017
The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtypeCarolina Schinke, Antje Hoering, Hongwei Wang, et al.
Oncoimmunology|November 15, 2021
Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in <i>Braf</i>-mutated melanomaMichael G White, Robert Szczepaniak Sloane, Russell G Witt, et al.
Clinical Medicine (London, England)|January 26, 2022
Utility of severity assessment tools in COVID-19 pneumonia: a multicentre observational studyAsim Ahmed, Sayed A Alderazi, Rumaisa Aslam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2023
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal GammopathiesLeire Burgos, Luis-Esteban Tamariz-Amador, Noemi Puig, et al.
Cancer Research|September 15, 2020
Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward OsimertinibYuting Sun, Brooke A Meyers, Barbara Czako, et al.
Nature|June 15, 2022
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapyChristopher P Vellano, Michael G White, Miles C Andrews, et al.
Pageof 31